Lehrstuhl für Innere Medizin III

FRA2 IS PLAYING A KEY ROLE IN THE CONTROL OF TREG DEVELOPMENT AND AUTOIMMUNITY (2016) Renoux F, Stellato M, Pachera E, Impellizzieri D, Dees C, Distler J, Kania G, et al. Conference contribution FEVER OF UNKNOWN ORIGIN (FUO) AND INFLAMMATION OF UNKNOWN ORIGIN (IUO): IS 18F-FDG-PET/CT A USEFUL FIRST LINE DIAGNOSTIC STRATEGY? (2016) Schoenau V, Vogel K, Engelbrecht M, Schmidt D, Kuwert T, Manger B, Schett G Conference contribution Apremilast Treatment and Long-Term (156-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Analysis of a Large Database of 3 Phase III, Randomized, Controlled Trials (2016) Gladman DD, Kavanaugh A, Gomez-Reino JJ, Wollenhaupt J, Cutolo M, Schett G, Lespessailles E, et al. Conference contribution Dipeptidyl-Peptidase-4 (DPP4) Positive Fibroblast Subpopulation Promotes Fibrosis and Are a Molecular Target for Treatment of Fibrosis (2016) Soare A, Rauber S, Wohlfahrt T, Dees C, Liang R, Zhang Y, Chen CW, et al. Conference contribution Activating Transcription Factor 3-a New Linkage Between Vasculopathy and Organ Fibrosis in Systemic Sclerosis (2016) Wohlfahrt T, Soare A, Mallano T, Gourlaouen M, Moss S, Maurer B, Distler O, et al. Conference contribution DISEASE PROGRESSION IN 282 PATIENTS WITH UNDIFFERENTIATED SSC - DATA FROM THE GERMAN NETWORK FOR SYSTEMIC SCLERODERMA (2016) Moinzadeh P, Blank N, Siegert E, Henes J, Susok L, Distler J, Juche A, et al. Conference contribution APREMILAST, AN ORAL PHOSPHODIESTERASE-4 INHIBITOR, IS ASSOCIATED WITH LONG-TERM (104-WEEK) IMPROVEMENTS IN ENTHESITIS AND DACTYLITIS IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED RESULTS FROM THREE PHASE III RANDOMIZED CONTROLLED TRIALS (2016) Gladman DD, Kavanaugh A, Adebajo AO, Gomez-Reino JJ, Wollenhaupt J, Cutolo M, Schett G, et al. Conference contribution Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-term (104-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Results from Three Phase III, Randomized, Controlled Trials (2016) Gladman D, Kavanaugh A, Adebajo A, Gomez-Reino J, Wollenhaupt J, Cutolo M, Schett G, et al. Conference contribution A LONGITUDINAL DUAL ENERGY COMPUTED TOMOGRAPHY STUDY ON THE EFFECT OF URATE LOWERING THERAPIES ON THE REDUCTION OF TOPHUS BURDEN IN PATIENTS WITH CHRONIC GOUT (2016) Ellmann H, Bayat S, D'Oliveira I, Englbrecht M, Araujo E, Mendonca S, Lell M, et al. Conference contribution A NEW METHOD FOR THE QUANTITATIVE ANALYSIS OF HAND MUSCLE VOLUME FOR PATIENTS WITH RHEUMATOID ARTHRITIS (2016) Friedberger A, Museyko O, Figueiredo C, Bäuerle T, Chaudry O, Grimm A, Schett G, Engelke K Conference contribution